Glenmark is set to launch a generic version of Teva’s Adderall tablets in strengths ranging from 5 mg to 30 mg, with distribution set to begin in May 2025. The company will launch ...

A Glenmark Pharmaceuticals factory in India did not meet current good manufacturing practice standards, according to an FDA report. Specifically, the FDA’s inspection revealed that the factory ...

This article originally appeared on ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.

(Judgment paragraphs 56-58). Damages were not an adequate remedy for Glenmark (or the NHS) either - but it was prudent to preserve the status quo. AZ’s arguments on ground 3 (including an ...

Glenmark gave no potential launch date for the generic approved by the FDA at 5 mg and 10 mg strengths. AZ did not mention the impact of generic competition for Farxiga in the US in its full year ...